Axial Spondyloarthritis
Musculoskeletal·MeSH: Axial Spondyloarthritis
Prevalence
310.0 / 100K
Incidence
7.3 / 100K/yr
7 drugs in development·6 companies·3 clinical trials
Drug Pipeline by Phase
Approved(2)
Phase 3(1)
| Drug | Company |
|---|---|
| secukinumab | Novartis AG (NVS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Axial Spondyloarthritis?
BioSniper tracks 7 drugs in development for Axial Spondyloarthritis across 6 companies.
How many clinical trials target Axial Spondyloarthritis?
There are 3 clinical trials targeting Axial Spondyloarthritis tracked by BioSniper.
What is the prevalence of Axial Spondyloarthritis?
The estimated prevalence of Axial Spondyloarthritis is approximately 310.0 per 100,000 population.
Deep-dive into Axial Spondyloarthritis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis